HPL financials Hoechst Pakistan Limited
Hoechst Pakistan Limited (HPL) has 7 financial years on file, from the year to 31 Dec 2018. The latest, the year to 31 Dec 2025 earned Rs 301.67 a share on sales of Rs 30.9 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 31 December. 4 of the last 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 31 Dec 2025 | 301.67 | Rs 30.9 bn | 36.5% | 9.4% | +56.7% |
| Year to 31 Dec 2024 | 192.56 | Rs 26.7 bn | 31.5% | 6.9% | +414.7% |
| Year to 31 Dec 2023 | 37.41 | Rs 21.4 bn | 25.9% | 1.7% | +116.4% |
| Year to 31 Dec 2022 | 17.29 | Rs 18.6 bn | 26.2% | 0.9% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 63.70 | Rs 7.8 bn | Rs 614.3 m | 7.9% | -29.8% |
| Quarter to 30 Jun 2026 | 152.94 | Rs 9.0 bn | Rs 1.5 bn | 16.4% | +86.6% |
| Quarter to 31 Mar 2026 | 74.71 | Rs 7.7 bn | Rs 720.6 m | 9.4% | — |
| Quarter to 30 Sep 2025 | 90.79 | Rs 8.3 bn | Rs 875.7 m | 10.6% | — |
| Quarter to 30 Jun 2025 | 81.94 | Rs 8.7 bn | Rs 790.3 m | 9.1% | — |
Annual report figures: income and balance sheet
From each annual report. A blank is a line this page does not show for that year.
| Year | Revenue | Gross profit | Profit after tax | Total assets | Equity | Liabilities | Return on equity | Current ratio | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Year to 31 Dec 2024 | Rs 26.7 bn | Rs 1.0 m | Rs 1.9 bn | Rs 13.6 bn | Rs 6.8 bn | — | 27.2% | — | unknown |
| Year to 31 Dec 2020 | — | Rs 4.0 m | Rs 83.7 m | Rs 8.7 bn | Rs 8.4 bn | — | 1.0% | — | unknown |
| Year to 31 Dec 2019 | Rs 14.5 bn | Rs 3.7 bn | Rs 155.0 m | Rs 7.7 bn | Rs 4.0 bn | Rs 3.7 bn | 3.8% | 1.64 | unknown |
| Year to 31 Dec 2018 | Rs 18.6 bn | Rs 4.9 bn | Rs 167.0 m | Rs 12.3 bn | Rs 5.1 bn | Rs 7.3 bn | 3.3% | 1.41 | unknown |
Source: annual report, page 25.
Ratios from the latest annual report
- Return on equity
- 27.2%
- Return on assets
- 13.7%
- Book value a share
- Rs 706.70
- Price to book value
- 5.65 times
- Debt to equity
- 0.99
- Equity as a share of assets
- 50.3%
- Gross margin
- 0.0%
- Operating margin
- 13.6%
As of 31 Dec 2024.
Cash flow
Where the cash came from and went
| Depreciation and amortisation | Rs 353.3 m |
| Operating cash flow | Rs 4.9 bn |
| Capital spending | Rs -798.0 m |
| Free cashworked out: operating cash flow less capital spending | Rs 4.1 bn |
| Dividends paid | Rs -1.5 bn |
| Change in cash | Rs 33.1 m |
| Cash at the start of the year | Rs 119.8 m |
| Cash at the end of the year | Rs 152.9 m |
Group accounts, year to 31 Dec 2025 · filed annual report, page 67
More on HPL
- HPL share price and overview
- HPL dividend history
- Pharmaceuticals sector
- IBLHL financials · IBL HealthCare Limited
- LIVEN financials · Liven Pharma Limited
- MACTER financials · Macter International Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- HALEON financials · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .